© 2023 St. Louis Public Radio
Play Live Radio
Next Up:
Available On Air Stations

Possible 'game-changer' in meth battle manufactured by St. Louis-area company

(via Flickr/ellie)
Pseudoephedrine, found in some cold medications, can be used to manufacture methamphetamine. But a new form of pseudophedrine manufactured by a St. Louis-area company apparently cannot be used to make the drug.

Some are calling it a "game-changer" in the battle against methamphetamine labs - a new form of pseudoephedrine that apparently can't be used to make the dangerous and addictive drug.

The formulation known as Tarex, was developed by Highland Pharmaceuticals, a suburban St. Louis company that hopes to have it on the market by summer under the brand name Releva.

Some narcotics officers believe Tarex holds promise in finally turning the tide against meth labs.

A key to meth-making is crystallization. Highland Pharmaceuticals says that rather than crystallizing when heated with chemicals used in meth-making, Tarex results in a gooey substance.

A Missouri House committee on Wednesday heard testimony on a proposal to require a prescription for pseudoephedrine, but it would exempt products like Tarex that can't be turned into meth.


Send questions and comments about this story to feedback@stlpublicradio.org.